EVALUATION AND MANAGEMENT OF THE MAN WHO HAS FAILED PRIMARY CURATIVE THERAPY FOR PROSTATE CANCER
- 1 November 1998
- journal article
- review article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 25 (4) , 591-601
- https://doi.org/10.1016/s0094-0143(05)70050-1
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Detection of Prostate Cancer Relapse With Prostate Specific Antigen Monitoring at Levels of 0.001 to 0.1 micro g./lJournal of Urology, 1997
- The Efficacy and Complications of Salvage Cryotherapy of the ProstateJournal of Urology, 1997
- Monoclonal Antibody Imaging of Occult Prostate Cancer in Patients With Elevated Prostate-Specific AntigenClinical Nuclear Medicine, 1996
- Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate Cancer: The relationship between nadir level and disease-free survivalJournal of Urology, 1996
- Impact of Moderate Dose of Postoperative Radiation on Urinary Continence and Potency in Patients with Prostate Cancer Treated with Nerve Sparing ProstatectomyJournal of Urology, 1996
- Haematogenous dissemination of prostatic epithelial cells during radical prostatectomyThe Lancet, 1995
- Radiotherapy for Isolated Increases in Serum Prostate-Specific Antigen Levels After Radical ProstatectomyMayo Clinic Proceedings, 1994
- Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancerEuropean Journal Of Cancer, 1993
- The fall and rise of prostate-specific antigen: Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancerCancer, 1993
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989